It is an exciting time in the treatment of people with bleeding disorders with many coagulation products having been recently approved by Health Canada or “in the pipeline” at various stages of clinical research. So many treatments, in fact, that it has become difficult to keep track of them all. To help everyone stay informed of their progress through clinical trials and regulatory approval, the CHS publishes four charts presenting all the products in the pipeline.
www.hemophilia.ca/products-in-the-pipeline
